Simron Singh
Impact in
- Neurology top 0.5%
- Neuroblastoma Research and Treatments
- Epidemiology top 0.5%
- Neuroendocrine Tumor Research Advances
Papers in
- Epidemiology 105
- Neuroendocrine Tumor Research Advances 102
- Oncology 93
- Lung Cancer Research Studies 64
- COVID-19 and healthcare impacts 12
- Cancer survivorship and care 7
- Co-authors
- Calvin Law (33 shared papers)Julie Hallet (28 shared papers)Ning Liu (14 shared papers)Refik Saskin (8 shared papers)Moisés Cukier (6 shared papers)David Chan (20 shared papers)Jonathan Strosberg (25 shared papers)Eva Segelov (14 shared papers)
- Journals
- Journal of Clinical Oncology (40 papers)Annals of Oncology (8 papers)Blood (5 papers)Neuroendocrinology (5 papers)Endocrine Related Cancer (5 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Simron Singh
168 papers receiving 3.9k citations
Simron Singh's Hit Papers
Peers
Comparison fields: 5 of 108
- Neurology 1.2k
- Epidemiology 2.5k
- Oncology 1.9k
- Otorhinolaryngology 194
- Gastroenterology 81
Countries citing papers authored by Simron Singh
This map shows the geographic impact of Simron Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simron Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simron Singh more than expected).
Fields of papers citing papers by Simron Singh
This network shows the impact of papers produced by Simron Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simron Singh. The network helps show where Simron Singh may publish in the future.
Co-authors
The 25 scholars most cited alongside Simron Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 182 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomes Hit paper breakdown → | 2014 | 626 |
| 2 | 2017 | 273 | |
| 3 | [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study Hit paper breakdown → | 2024 | 145 |
| 4 | 2020 | 125 | |
| 5 | 2015 | 123 | |
| 6 | 2016 | 116 | |
| 7 | 2005 | 112 | |
| 8 | 2020 | 92 | |
| 9 | 2017 | 74 | |
| 10 | 2014 | 71 | |
| 11 | 2014 | 69 | |
| 12 | 2017 | 67 | |
| 13 | 2016 | 67 | |
| 14 | 2018 | 57 | |
| 15 | 2010 | 56 | |
| 16 | 2010 | 55 | |
| 17 | 2016 | 54 | |
| 18 | 2012 | 51 | |
| 19 | 2011 | 47 | |
| 20 | 2018 | 46 |
About Simron Singh
Simron Singh is a scholar working on Epidemiology, Oncology, Neurology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 182 papers that have together received 4.0k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (102 papers), Lung Cancer Research Studies (64 papers), Neuroblastoma Research and Treatments (49 papers), COVID-19 and healthcare impacts (12 papers), Head and Neck Cancer Studies (8 papers), Economic and Financial Impacts of Cancer (8 papers), Cancer survivorship and care (7 papers) and Patient Satisfaction in Healthcare (5 papers). The work is most often cited by research in Neurology (1.2k citations), Epidemiology (2.5k citations), Oncology (1.9k citations), Otorhinolaryngology (194 citations) and Gastroenterology (81 citations). Simron Singh has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Calvin Law, Julie Hallet, Ning Liu, Refik Saskin, Moisés Cukier, David Chan, Jonathan Strosberg, Eva Segelov, Matthew C. Cheung and Pamela L. Kunz. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, Neuroendocrinology and Endocrine Related Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.